The skin is one of the largest organs in the body in surface area and weight. The skin consists of two layers: the epidermis and the dermis. Beneath the dermis lies the hypodermis or subcutaneous fatty tissue. (Picture 2) The skin has three main functions:
Sunlight is essential for synthesizing vitamin D. Sunlight also has beneficial effects on mood. However, ultraviolet (UV) radiation (290 to 400 nm) is responsible for several acute and chronic detrimental effects on human skin, including sunburn, photoaging, and skin cancer (Baron, 2021). (Picture 3)
Ultraviolet B (UVB; 290 to 320 nm) and ultraviolet A (UVA; 320 to 400 nm) can cause sunburn. Wavelengths that are the most effective at inducing erythema are in the UVB range (Young & Tewari, 2021).
UVB (290 to 320 nm), representing only 5% of the UV radiation reaching the earth's surface, includes the biologically most active wavelengths. UVB is responsible for: (Baron, 2021)
Approximately 95% of the UV radiation reaching the earth's surface is UVA (320 to 400 nm).
Photoprotection is crucial to prevent or reduce the potential harms associated with UV exposure and includes: (Baron, 2021)
Sunburn is common. In the United States (US), the estimated sunburn prevalence (≥ 1 sunburn in the past 12 months) among all adults was approximately 34% in 2005, 37% in 2010, and 31% in 2015. Prevalence ranging from 20% to 70% has been reported in cross-sectional studies in Europe and Australia. In the US, sunburn has also been reported in 13% of African Americans and 30% of Hispanics (Young & Tewari, 2021).
Sunburn occurs more frequently among adolescents and young adults. In nationwide surveys in the US, approximately 70% of adolescents aged 11 to 18 years and 50% of adults aged 18 to 29 reported at least one sunburn in the previous year (Young & Tewari, 2021).
Factors that increase the risk for sunburn include:
The susceptibility to sunburn is highly variable among individuals. Phenotypic characteristics that confer high susceptibility to sunburn include fair skin, blue eyes, and red or blond hair. Increased susceptibility to sunburn is also a marker of increased risk of melanoma and nonmelanoma skin cancer (Young & Tewari, 2021).
An individual's susceptibility to sunburn can be assessed by determining the minimum erythema dose (MED), the lowest dose of UVR delivered to the skin that produces marginated erythema in the irradiated site 24 hours after a single exposure. The MED is considered the threshold for sunburn and is widely used as a dose unit in phototherapy, experimental photobiology, and determining a sunscreen's sun protection factor (Young & Tewari, 2021).
In clinical practice, the self-reported tendency to develop sunburn or tanning after sun exposure is used to determine an individual's skin phototype (Table 1).
|Skin type||Unexposed Skin Color||Reaction to Sun Exposure*|
|I||White||Always burns, never tan|
|II||White||Always burns, minimal tan|
|III||White to olive||Burns minimally, gradually tans|
|IV||Light brown||Burns minimally, tans well|
|V||Brown||Very rarely burns, tans profusely|
|VI||Dark brown to black||Never burns, tans deeply|
*After the first one hour of sun exposure on untanned skin on the first spring day.
People who have darker skin types (IV to VI) do not develop visible erythema without higher doses of UVR. The MED of skin type IV that tans easily is twice the MED of a skin type I that does not tan. There is an overlap of MED values amongst different skin types. People with skin types I and I may burn with repeated suberythemal exposures (e.g., 0.5 MED).
Wavelengths that most effectively produce a skin response are shown on an action spectrum. The most effective wavelengths correspond to the absorption spectrum for the chromophore (a molecule that absorbs UVR photons). Wavelengths most effective for erythema in sunlight are in the UVB range. UVA can cause erythema, but doses nearly 1,000 times higher than UVB are required (Young & Tewari, 2021).
The sun is primarily a UVA source, with UVB representing up to approximately 5% of the UVR reaching the earth's surface, although this contributes to over 80% of the erythemal effective energy. Thus, the risk of sunburn is highest when the UVB to UVA ratio is high, as occurs between 11 AM and 3 PM in the summer months in temperate climates and particularly at latitudes approaching the equator (Young & Tewari, 2021).
Many biochemical and cellular changes occur in the epidermis and dermis before the erythema becomes evident in the sunburn response. However, the initiating events are incompletely understood, and the nature of the chromophore(s) (molecule absorbing the UV light) for erythema is still uncertain. The observation that the action spectrum for erythema is very similar to that for the induction of cyclobutane pyrimidine dimers (CPDs) suggests that DNA photodamage may trigger the inflammatory cascade in sunburn. UVB-mediated pigmentation (delayed tanning) can also be triggered by CPD, suggesting that inflammation and sunburn are also important in the tanning response (Young & Tewari, 2021).
Early events include:
Erythema becomes clinically apparent 3 to 6 hours after exposure, peaks at 12 to 24 hours, and usually subsides at 72 hours. Neutrophilic infiltration starts approximately 3 hours after UVB exposure, peaks at 24 hours, and continues up to 48 hours later (Young & Tewari, 2021).
The major mediators of UVB-induced inflammation are prostaglandins and nitric oxide (NO) over 72 hours after UVB exposure; proinflammatory and anti-inflammatory eicosanoids have been identified in suction blister fluid. In the first 24 to 48 hours, vasodilatory prostaglandins (PG) PGE2, PGF2a, and PGE3 are associated with increased COX-2 expression at 24 hours. At 4 to 72 hours, chemoattractant prostaglandins (11, 12, and 8-monohydroxy-eicosatetraenoic acid [HETE]) appear, whereas the anti-inflammatory 15-HETE is maximally present at 72 hours (Young & Tewari, 2021).
Several proinflammatory cytokines, including TNF-alpha, IL-1, IL-6, and IL-8, are elevated after UVB exposure. Cytokines may play several roles in UVB-induced inflammation, including activation of transcription factors, upregulation of endothelial adhesion molecules, and recruitment of neutrophils to the skin (Young & Tewari, 2021).
The magnitude of the exposure dose affects the extent and time course of the histological changes observed after UVB exposure.
The patient should seek medical care if experiencing:
Clinical manifestations of sunburn range from mild erythema to highly painful erythema with edema, vesiculation, and blistering. (Picture 1 above and Table 2). Blistering indicates superficial partial-thickness or, rarely, deep partial-thickness burn (Young & Tewari, 2021).
|Superficial (epidermal)||Painful||3 to 6 days|
|Superficial partial-thickness||Painful to touch, air, and temperature||7 to 21 days|
|Deep partial-thickness||Painful to pressure only||>21 days, usually requires surgical treatment|
|Full-thickness||Deep pressure only||Rare, unless surgically treated|
|Deeper injury (i.e., fourth degree)||Extends into fascia or muscle||Deep pressure||Never, unless surgically treated|
Erythema is usually first noted 3 to 6 hours following sunlight exposure, peaks at 12 to 24 hours, and in most cases subsides at 72 hours. The skin areas that were covered or shaded are typically spared (Young & Tewari, 2021). (Picture 1)
Increased skin sensitivity to heat and mechanical pressure is characteristic and present even in mild cases. In severe cases, systemic symptoms may develop, including headache, fever, nausea, and vomiting (Young & Tewari, 2021).
The erythema typically resolves in three to seven days. Blisters heal without scarring in 7 to 10 days. Scaling, desquamation, and tanning are noted four to seven days after exposure (Young & Tewari, 2021).
Multiple permanent brown macules, often with irregular borders, may occur in light-skinned individuals after sunburn (sunburn-induced solar lentigines) (Young & Tewari, 2021). (Picture 4)
Based on the following clinical findings, the diagnosis of sunburn is usually straightforward:
|Anticancer Drugs: Dacarbazine, Fluorouracil, Flutamide, Methotrexate, Vinblastine|
|Antidepressants: Amitriptyline, Amoxapine, Clomipramine, Desipramine, Doxepin, Imipramine, Maprotiline, Phenelzine, Protriptyline, Trazodone, Trimipramine|
|Antihistamine: Cyproheptadine, Diphenhydramine|
|Antihypertensives: Captopril, Diltiazem, Methyldopa, Minoxidil, Nifedipine|
|Antimicrobials: Ciprofloxacin, Clofazimine, Dapsone, Demeclocycline, Doxycycline, Enoxacin, Flucytosine, Griseofulvin, Lomefloxacin, Minocycline, Nalidixic acid, Norfloxacin, Ofloxacin, Oxytetracycline, Pyrazinamide, Sulfonamides, Tetracycline, Trimethopterin|
|Antiparasitic Drugs: Chloroquine, Quinine|
|Antipsychotic Drugs: Chlorpromazine, Fluphenazine, Haloperidol, Perphenazine, Prochlorperazine, Thioridazine, Thiothixene, Trifluoperazine, Triflupromazine|
|Diuretics: Acetazolamide, Amiloride, Bendroflumethiazide, Benzthiazide, Chlorthiazide, Furosemide, Hydrochlorothiazide, Hyroflumethiazide, Methyclothiazide, Metolazone, Polythiazide, Trimterene, Trichlormethiazide|
|Hypoglycemics: Acetohexamide, Chlorpropamide, Glipizide, Glyburide, Tolazamide, Tolbutamide*|
|NSAIDs: Difluisal, Ibuprofen, Indomethacin, Ketoprofen, Nabumetone, Naproxen, Phenylbutazone, Piroxicam*, Sulindac|
|Sunscreens: Aminobenzoic acids*, Avobenzone, Benzophenonones*, Cinnamates, Homosalate, Menthyl anthranilate, PABA esters*|
|Others:Alpazolam, Amantadine, Amiodarone*, Benzocaine, Benzyl peroxide, Bergamot oil, oils of citron, lavender, lime, sandalwood, cedar*, Carbamazepine, Chlordiazepoxide, Clofibrate, Desoximetasone, Disopyramide, Etretinate, Fluorescein, Gold salts, Hexachlorophene, Isotretinoin, 6-methylcoumarin*, Musk ambrette*, Oral contraceptives, Promethazine*, Quinidine sulfate, Tretinoin, Trimeprazine|
Contact with topical photosensitizers
Use of indoor tanning equipment
Exposure to UVB phototherapy or UVA photochemotherapy (PUVA) (Young & Tewari, 2021)
Exposure to phototoxic drugs or topical photosensitizer substances and for individuals with genetic disorders causing increased sensitivity to UVR can result in exaggerated sunburn reactions that may occur as a result of:
Several idiopathic photodermatoses may mimic sunburn. However, they can be easily differentiated from sunburn based upon their clinical presentation and time course:
Sunburn is a self-limiting condition that may take two days for the severity of the sunburn to become evident and several more days for the skin to begin to heal (Sunburn, 2020).
Sunburn usually resolves in a few days. No specific therapies exist to reverse the skin damage and hasten healing time. Management involves the symptomatic treatment of skin inflammation and control of discomfort/pain. Management strategies include:
Blistered areas should not be broken open but gently cleaned with mild soap and water and covered with sterile dressings (Young & Tewari, 2021).
Ruptured blisters should be gently cleaned with mild soap and water. A topical antimicrobial or antibiotic such as silver sulfadiazine or mupirocin 2% ointment should be used to prevent bacterial superinfection, followed by applying wet dressings such as saline or petrolatum impregnated gauzes (Young & Tewari, 2021).
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) should be initiated to treat pain and skin inflammation as soon as the first symptoms become apparent and continue for 24 to 48 hours.
The efficacy of oral NSAIDs for the symptomatic treatment of sunburn has not been adequately evaluated in randomized trials (Young & Tewari, 2021). However, some small studies show benefits if started immediately after the burn.
Although topical corticosteroids are frequently used, there is little evidence that they reduce symptoms and the healing time of sunburn (Young & Tewari, 2021).
Topical diclofenac gel has been reported to reduce pain and inflammation from sunburn. However, topical diclofenac may induce allergic contact dermatitis and photoallergic contact dermatitis (Young & Tewari, 2021).
Applying '---caine' products, such as benzocaine, should be avoided. Such creams can irritate the skin or cause an allergic reaction. Benzocaine has been linked to a rare but potentially deadly condition that decreases the amount of oxygen that the blood can carry (methemoglobinemia) (Sunburn, 2020).
Patients with extensive blistering sunburn, severe pain, and systemic symptoms (e.g., fever, headache, vomiting, and dehydration) may require hospitalization for fluid replacement and parenteral analgesia (Young & Tewari, 2021). (Table 3)
|Partial-thickness burns greater than 10% of TBSA.|
|Burns that involve the face, hands, feet, genitalia, perineum, or major joints.|
|Third-degree burns in any age group.|
|Electrical burns, including lightning injury.|
|Burn injury in patients with preexisting medical disorders could complicate management, prolong recovery, or affect mortality.|
|Any patient with burns and concomitant trauma (such as fractures) in which the burn injury poses the greatest risk for morbidity or mortality. If the trauma poses a greater immediate risk, the patient may be stabilized initially in a trauma center before being transferred to a burn unit. Physician judgment will be necessary for such situations and should be in concert with the regional medical control plan and triage protocols.|
|Burned children in hospitals without qualified personnel or equipment for the care of children.|
|Burn injury in patients who will require special social, emotional, or rehabilitative intervention.|
TBSA: total body surface area.
* A burn center may treat adults, children, or both. Burn injuries that should be referred to a burn center include any criteria listed.
There is no evidence that oral corticosteroids are useful in severe sunburn.
Intense, repeated sun exposure that results in sunburn increases the risk of other skin damage and certain diseases. These include:
Premature aging of the skin (photoaging)
Photoaging, also called extrinsic aging, is premature skin aging resulting from prolonged and repeated exposure to solar radiation. In individuals with light phototypes (see Table 2 above), sun-induced changes include:
In particular, in skin types I or II populations, atrophic and dysplastic changes (e.g., actinic keratoses) with fine wrinkling are common signs of photoaging. In skin types III or IV populations, predominant features include increased skin thickness, deep wrinkles, and a leathery appearance. Hyperpigmented macules and mottled hyperpigmentation are also common features of photodamaged skin in phototypes I to IV.
Other signs of severe photodamage include:
In photoaging in individuals with phototypes V to VI, the effects of photodamage generally occur 10 to 20 years later. They are less severe than those observed in individuals with lighter skin due to lower susceptibility to sun damage. In individuals with heavily pigmented skin, melanosomes increase in number and size, contain more melanin, are more widely distributed in the epidermis, and are more slowly degraded than in lightly pigmented skin, leading to greater photoprotection. With darker skin, premature aging typically manifests in the midface with prominent nasolabial folds due to increased skin laxity but fewer wrinkles. Prominent features in these individuals include:
While UV exposure is a major determinant of skin aging in individuals with light skin tones, its role is limited in those with highly pigmented skin. The changes of photodamage are superimposed on the changes caused by chronologic aging (the so-called intrinsic or programmed aging). They are responsible for most of the age-associated features of skin appearance.
Photodamage can be partially prevented and reversed with proper sun protection and various prescription medications. However, concerns about photoaging are primarily cosmetic and are influenced by geographic differences, culture, and personal values (Chien & Kang, 2021).
Precancerous skin lesions
Precancerous skin lesions appear as rough, scaly patches in areas that have been damaged by the sun. They are usually found on light-skinned individuals in sun-exposed areas of the:
These patches can evolve into skin cancer (also called actinic keratosis) and solar keratoses.
Excessive sun exposure, even without sunburn, increases the risk of skin cancer, such as melanoma. It can damage the DNA of skin cells. Sunburns in childhood and adolescence may increase the risk of developing melanoma later.Skin cancer develops mainly on areas of the body most exposed to sunlight, including the following:
Some types of skin cancer appear as a small growth or a sore that bleeds easily, crusts over, heal, and then reopens. An existing mole may change with melanoma, or a new, suspicious-looking mole may develop. A type of melanoma called lentigo maligna develops in areas of long-term sun exposure. It starts as a tan flat spot that slowly darkens and enlarges.
Other types of skin cancer include:
Eyes, which are extremely sensitive to the sun's UV light, can burn. Too much UV light damages the:
Sunburned eyes may feel painful or gritty.
Skin signs/symptoms may include:
Any exposed part of the body, including the earlobes, scalp and lips, can burn. Even covered areas can burn if, for example, clothing has a loose weave that allows the UV light through.
Sunburn signs and symptoms usually appear within a few hours after sun exposure. However, it may take a day or more to know how severe the sunburn is.
Within a few days, the body may start to heal itself by peeling the damaged skin's top layer. After peeling, the skin may temporarily have a distinctive color and pattern. A bad sunburn may take several days to heal.
Prevention of sunburn involves:
Individuals should be advised to seek shade or reduce exposure to sunlight, particularly in the summer months and between 10:00 AM and 4:00 PM when sunlight intensity is greatest. (Young & Tewari, 2021)
When possible, try to schedule outdoor activities for other times. If unable to do that, limit time in the sun and seek shade when possible (Sunburn, 2020).
Wearing clothes is important for sun protection (Baron, 2021). Protective clothing such as long sleeves and broad-brimmed hats should be worn outdoors (Young & Tewari, 2021). The degree of protection provided by clothes is defined by the ultraviolet protection factor (UPF), which indicates how effective a fabric is at blocking out solar UV radiation (Baron, 2021). Factors that contribute to the UPF rating of a fabric are:
The UPF classification is certified by national and international organizations (e.g., American Sun Protection Association, Skin Cancer Foundation). The categories are UPF:
A garment's photoprotective capacity may also be enhanced by washing with detergents containing optical whitening agents (Baron, 2021). Shrinkage from repeated washing and drying may improve the UPF.
Avoid Sun Tanning and Tanning Beds (Sunburn, 2020)
Getting a base tan does not decrease the risk of sunburn. Intentional tanning by using UVA tanning beds does not protect against the risk of sunburn (Young & Tewari, 2021). Although suberythemal repetitive exposure to UVA increases skin pigmentation (immediate tanning due to oxidation and redistribution of existing melanin), they do not increase melanin production and provide little or no photoprotection against subsequent UV exposures.
Liberal Use of Broad Spectrum Sunscreens
Sunscreens are topical preparations containing filters that reflect or absorb radiation in the UV wavelength range. Broad-spectrum sunscreens are generally combinations of sunscreen products that absorb both UVA and UVB radiation (Baron, 2021).
Broad-spectrum sunscreens with a sun protection factor (SPF) 30 or higher should be regularly used when performing outdoor activities, e.g., recreational, work, sports etc., in sunny weather, especially in regions with high insolation levels (Young & Tewari, 2021). Apply water-resistant sunscreen and lip balm with an SPF of 30 or greater and broad-spectrum protection against UVA and UVB rays (Sunburn, 2020).
Sunscreens should be applied 15 to 30 minutes before sun exposure to allow the formation of a protective film on the skin and reapplied at least every two hours and after swimming or sweating (Young & Tewari, 2021). It is recommended to wait for at least a few minutes (ideally, 10 to 20) following sunscreen application before dressing (Baron, 2021). In the US, the US Food and Drug Administration (FDA) requires the SPF to remain the same before and after water immersion, with the terms "water-resistant" and "very water-resistant," meaning that the SPF is maintained after 40 or 80 minutes of activity in water or sweating, respectively (Young & Tewari, 2021)
Sunscreens demonstrate a reduction in sun damage, squamous cell carcinomas, melanomas, and photoaging if used appropriately (Young & Tewari, 2021). If an individual is also using insect repellent, the sunscreen should be applied first. The American Academy of Dermatology does not recommend insect repellent with sunscreen products (Sunburn, 2020).
The FDA requires all sunscreen to retain its original strength for at least three years (Sunburn, 2020). Check the sunscreen labels for directions on storing and expiration dates. Throw away sunscreen if it has expired or is more than three years old.
Regardless of skin phototype, all individuals are subject to the potential adverse effects of UV radiation and benefit from sunscreen use (Baron, 2021). Sunscreens are beneficial for individuals with light skin (phototypes I, II, and III) who are more susceptible to acute sunburn and chronic (photoaging, skin cancer) adverse effects of excessive sun exposure. Light-skinned individuals should regularly use broad-spectrum sunscreens with an SPF of 30 or higher when performing outdoor activities in sunny weather, especially in regions with a high insolation level. Because individuals typically do not apply sunscreen in the recommended amount (approximately 1 to 1.5 ounces or 6 to 9 teaspoons per total body application), they may benefit from a higher SPF.
Sunscreen products with SPF 15 are generally recommended for daily use. Sunscreen-containing cosmetics (e.g., facial moisturizers, foundations) may improve photoprotection compliance. Most cosmetic products are formulated to provide an SPF of 15 to 30 and may or may not be labeled as a broad spectrum. Cosmetics providing broad-spectrum protection should be preferred to those containing only UVB filters.
The "Teaspoon Rule" (Baron, 2021).
Clinicians should instruct patients to adopt simple application techniques that ensure adequate amounts of sunscreen to the exposed areas. One of these is the so-called "teaspoon rule." It involves the application of:
Benefits of Sunscreen
Skin cancers - There is evidence from observational studies and randomized trials that sunscreens prevent the development of actinic keratoses and squamous cell carcinomas (Baron, 2021). Clinicians counsel patients with sun-sensitive skin must type about sun protection because susceptibility to sunburn is a marker of genetic susceptibility to skin cancer and is associated with an increased risk of melanoma at all ages (Young & Tewari, 2021)
Photoaging- Skin damage from UV exposure accumulates over time. In fair-skinned individuals, a substantial amount of photodamage manifests by age 40. Sunscreens may prevent skin changes such as pigmentation and wrinkling attributable to chronic photodamage or photoaging (Chien & Kang, 2021).
Photodermatoses - Broad-spectrum sunscreens with high SPF are generally used to prevent photodermatoses, which can be elicited by either UVA or UVB (Elmets, 2022).
Protect Eyes - Sun damage to the eyes can happen all year long, especially in sunnier climates. UV-blocking sunglasses should be worn along with broad-rimmed hats when outside. Choose either 99% or 100% UVA and UVB protection or UV 400 protection sunglasses. UV rays also pass through clouds, so it is important to use sun protection even when cloudy. Check the UV rating on the label when buying new glasses. Never look at the sun directly, as this can cause severe damage to the retina even when cloudy. Darker lenses are not necessarily better at blocking UV rays. Wear sunglasses that fit close to the face or have wrap-around frames. Help children and the elderly to protect their eyes with hats and sunglasses.
Protect Infants and Young Children - Infants younger than six months should be kept out of direct sunlight. The American Academy of Pediatrics recommends using other forms of sun protection, such as shade or clothing (e.g., lightweight pants, long-sleeved shirts, brimmed hats) for babies under six months (Sunburn, 2020).
The American Academy of Dermatology recommends avoiding sunscreen products on infants younger than six months (Sunburn, 2020). Keep infants cool, hydrated, and out of direct sunlight. If sun protective clothing and shade are not available, sunscreen should be applied to infants and toddlers (Sunburn, 2020). A minimal amount of sunscreen with at least 15 SPF can be applied to small areas, such as the infant's face and the back of the hands (Baron, 2021).
Since infants have an immature skin barrier, sunscreen products should be non-irritating to the skin and eyes and have a low sensitization potential (Baron, 2021). Products containing physical blockers (titanium oxide, zinc oxide) should be used to cause less skin irritation (Sunburn, 2020). These products are preferred for infants and children because they offer broad-spectrum protection and have minimal irritation, sensitization, and skin penetration potential (Baron, 2021).
Awareness of Sun-sensitizing Medications - Some common prescription and over-the-counter drugs, including antibiotics, retinoids, and ibuprofen, make skin more sensitive to sunlight. A pharmacist or MD should inform the patient about the side effects of their medications (Sunburn, 2020).
Mrs. Vinge is a 33-year-old Caucasian female who comes to Urgent Care at 0800 with c/o a painful, red sunburn for the past three days. She had traveled to Hawaii with her two teenagers, 14 and 16-year-olds. They had wanted to learn to surfboard, having never done so before. Mrs. Vinge then proceeded to take the teenagers out on their surfboards and she with hers. The teenagers had applied sunscreen lotion, but Mrs. Vinge had not. She had floated on her surfboard, lying prone with her chest raised on her elbows to guard the teenager. She wore a modest bikini.
Counsel patient to:
Diagnosis: Superficial partial-thickness burns covering approximately 80% of the body.
Patient with superficial partial-thickness burns due to lack of wearing sunscreen.
Follow-up with Primary Care physician in seven days or sooner should symptoms worsen.
Sunburn is an acute, delayed, and transient inflammatory response of the skin to excessive exposure to UVR from natural sunlight or artificial sources. Both UVA and UVB can cause sunburn. However, the most effective wavelengths in inducing erythema are in the UVB range (290 to 320 nm).
Clinical manifestations of sunburn include painful erythema with or without edema, vesiculation, and blistering. Erythema is usually first noted 3 to 5 hours following sunlight exposure, peaks at 12 to 24 hours, and usually subsides at 72 hours.
The diagnosis of sunburn is usually straightforward, based on clinical findings and a history of exposure to sunlight or artificial sources of UV radiation.
Sunburn is a self-limiting condition. Cool compresses or soaks, calamine lotion, or aloe vera-based gels may be used to relieve skin discomfort. For the treatment of skin pain and inflammation, oral NSAIDs are advocated.
Patients with extensive blistering sunburn, severe pain, and systemic symptoms may require hospitalization for fluid replacement and parenteral analgesia.
Sunscreens are topical preparations containing inorganic (mineral) or organic substances that reflect, scatter, or absorb UV radiation in UVA and UVB wavelength ranges. Broad-spectrum sunscreens are generally combinations of sunscreen products that absorb both UVA and UVB radiations.
Regardless of skin phototype, everyone is subject to the potential adverse effects of UV radiation and may benefit from sunscreen. However, sunscreens are beneficial for individuals with light skin (phototypes I, II, and III) who are more susceptible to sunburn, photoaging, and skin cancer.
Broad-spectrum products with an SPF of 30 or higher are recommended for individuals performing outdoor work, sports, or recreational activities.
Sunscreens must be applied liberally, repeatedly, and to all sun-exposed skin to provide effective protection. Simple, practical rules, such as the "teaspoon rule," may determine the adequate amount of sunscreen to apply to certain body areas. Sunscreen should be applied 15 to 30 minutes before sun exposure to allow the formation of a protective film on the skin and reapplied every two hours.
Sunscreens generally have an excellent safety profile, and there is no evidence of systemic adverse effects related to percutaneous absorption. For those concerned about systemic absorption of organic sunscreens, sunscreens that contain inorganic constituents (zinc oxide, titanium dioxide) can be recommended. Organic sunscreens may rarely induce allergic and irritant contact dermatitis, phototoxic and photoallergic reactions, or contact urticaria.
Wearing clothes is important for sun protection. The degree of photoprotection provided by clothes is defined by the UPF, which indicates how effective a fabric is at blocking out solar ultraviolet radiation. Yarn composition, tightness of the weave, and dark colors increase a garment's UPF.
CEUFast, Inc. is committed to furthering diversity, equity, and inclusion (DEI). While reflecting on this course content, CEUFast, Inc. would like you to consider your individual perspective and question your own biases. Remember, implicit bias is a form of bias that impacts our practice as healthcare professionals. Implicit bias occurs when we have automatic prejudices, judgments, and/or a general attitude towards a person or a group of people based on associated stereotypes we have formed over time. These automatic thoughts occur without our conscious knowledge and without our intentional desire to discriminate. The concern with implicit bias is that this can impact our actions and decisions with our workplace leadership, colleagues, and even our patients. While it is our universal goal to treat everyone equally, our implicit biases can influence our interactions, assessments, communication, prioritization, and decision-making concerning patients, which can ultimately adversely impact health outcomes. It is important to keep this in mind in order to intentionally work to self-identify our own risk areas where our implicit biases might influence our behaviors. Together, we can cease perpetuating stereotypes and remind each other to remain mindful to help avoid reacting according to biases that are contrary to our conscious beliefs and values.